Nath Bio-Genes (India) Limited (BOM:537291)
India · Delayed Price · Currency is INR 175.55
+4.15 (2.42%)
At close: May 29, 2026
Nath Bio-Genes (India) Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,329 | 2,452 | 2,772 | 3,308 | 2,684 | 4,055 | |
Market Cap Growth | 10.24% | -11.54% | -16.20% | 23.22% | -33.79% | -28.93% |
Enterprise Value | 3,954 | 3,993 | 4,026 | 4,283 | 3,836 | 4,810 |
Last Close Price | 175.55 | 127.65 | 144.19 | 170.24 | 137.35 | 204.16 |
PE Ratio | 8.00 | 5.89 | 7.18 | 8.35 | 7.67 | - |
PS Ratio | 0.75 | 0.55 | 0.76 | 0.99 | 0.89 | 1.46 |
PB Ratio | 0.49 | 0.36 | 0.43 | 0.54 | 0.47 | 0.75 |
P/TBV Ratio | 0.49 | 0.36 | 0.44 | 0.55 | 0.48 | 0.77 |
P/FCF Ratio | - | - | 28.69 | 6.92 | 7.57 | - |
P/OCF Ratio | - | - | 15.77 | 4.43 | 7.00 | 23.78 |
EV/Sales Ratio | 0.89 | 0.90 | 1.10 | 1.29 | 1.27 | 1.73 |
EV/EBITDA Ratio | 7.54 | 7.61 | 7.91 | 8.56 | 7.85 | 12.78 |
EV/EBIT Ratio | 8.16 | 8.24 | 8.54 | 9.16 | 8.36 | 13.92 |
EV/FCF Ratio | -25.38 | - | 41.67 | 8.96 | 10.81 | - |
Debt / Equity Ratio | 0.20 | 0.20 | 0.19 | 0.18 | 0.18 | 0.17 |
Debt / EBITDA Ratio | 2.64 | 2.64 | 2.41 | 2.21 | 2.15 | 2.47 |
Debt / FCF Ratio | - | - | 12.68 | 2.31 | 2.97 | - |
Net Debt / Equity Ratio | 0.09 | 0.09 | 0.05 | 0.05 | 0.12 | 0.16 |
Net Debt / EBITDA Ratio | 1.19 | 1.19 | 0.66 | 0.66 | 1.38 | 2.36 |
Net Debt / FCF Ratio | -4.01 | -4.01 | 3.48 | 0.69 | 1.89 | -22.44 |
Asset Turnover | 0.42 | 0.42 | 0.38 | 0.40 | 0.39 | 0.36 |
Inventory Turnover | 0.51 | 0.51 | 0.32 | 0.41 | 0.38 | 0.42 |
Quick Ratio | 0.41 | 0.41 | 0.51 | 0.68 | 0.66 | 0.50 |
Current Ratio | 1.97 | 1.97 | 1.89 | 2.18 | 2.40 | 2.41 |
Return on Equity (ROE) | 6.29% | 6.29% | 6.16% | 6.70% | 6.28% | -11.67% |
Return on Assets (ROA) | 2.85% | 2.85% | 3.09% | 3.49% | 3.74% | 2.83% |
Return on Invested Capital (ROIC) | 5.53% | 6.13% | 6.79% | 6.95% | 6.99% | 5.26% |
Return on Capital Employed (ROCE) | 6.90% | 6.90% | 7.10% | 7.60% | 8.00% | 6.30% |
Earnings Yield | 12.50% | 16.98% | 13.93% | 11.98% | 13.04% | -16.62% |
FCF Yield | -4.68% | -6.35% | 3.49% | 14.46% | 13.22% | -0.98% |
Dividend Yield | 1.17% | 1.57% | 1.39% | 1.18% | 1.46% | 0.98% |
Payout Ratio | 9.13% | 9.13% | 9.85% | 9.59% | 10.86% | - |
Buyback Yield / Dilution | -4.41% | -4.41% | - | - | - | - |
Total Shareholder Return | -3.25% | -2.85% | 1.39% | 1.18% | 1.46% | 0.98% |